Navigation Links
Dutch Ambassador Visits DSM in North Carolina

PARSIPPANY, N.J., March 29, 2011 /PRNewswire/ -- Royal DSM, the global Life Sciences and Materials Sciences company, hosted Her Excellency the Ambassador of the Kingdom of the Netherlands to the United States Ms. Renee Jones-Bos at its Greenville, North Carolina facilities on March 28, 2011.Ambassador Jones-Bos met with DSM's management from their pharmaceuticals business and Dyneema-Ultra-High Molecular Weight Polyethylene fiber operations, and toured their sites to gain insight and understanding into DSM's business, and the Greenville community.

DSM is one of Greenville's, and Pitt County's, largest employers with nearly 1,200 employees working at its Greenville Pharmaceutical and Dyneema facilities, which operate at the same location. DSM has additional operations in North Carolina in Stanley, and has 28 operating sites in the United States with nearly 4,000 employees; and 22,000 employees world wide.

DSM has been in continuous operation for more than 100 years, originating in the Limburg Province of the Netherlands as a coal mining company. It has transformed itself into a well established Life Sciences & Material Sciences company, focused on creating brighter lives for people today and generations to come. DSM maintains its corporate headquarters in Heerlen, the Netherlands and remains proud of its Dutch roots and history, and the long standing and mutually beneficial friendship between the Dutch and American people dating back 400 years.

DSM maintains longstanding ties and an excellent relationship with the Dutch Embassy in the United States and is honored that Madam Ambassador Ms. Jones-Bos visited its Greenville facility and discussed with DSM management and the community how the Dutch and American people can continue to work together to drive economic growth, reduce barriers to trade and further key drivers to DSM's business – innovation and sustainability.

Recently, the Dutch Embassy released a report, Economic Ties Between the USA and the Netherlands, which details the economic imprint the Netherlands has in each state, an imprint that supports more than 700,000 jobs in the U.S.

Ambassador Jones-Bos stated: "DSM is a perfect example of the strong economic ties between the Netherlands and North Carolina. Dutch companies in 'the Tar Heel State' such as DSM support more than 22,000 jobs. In fact, the Netherlands is the 6th largest foreign investor in the state. "

Alexander Wessels, Chairman of DSM North America and CEO and President DSM Pharmaceutical Products added: "We are honored and delighted to have been able to welcome Madam Ambassador to Greenville; important operations for North Carolina, and for DSM.  We look forward to continuing and strengthening our relationship with the Embassy."

DSM – Bright Science. Brighter Living.™

Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of about euro 9 billion. The company is listed on NYSE Euronext. More information can be found at

Forward-looking statements

This press release may contain forward-looking statements with respect to DSM’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.For more information:DSM North America

DSM North AmericaHugh Welsh

Sheetal Bhadekartel. +1 973 257 8208

tel: +1 973 257 8323e-mail

e-mail: Sheetal.Bhadekar@dsm.comCarla BundyPress OfficerRoyal Netherlands Embassy202-274-2632/ (c)

SOURCE DSM Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. InteRNA Technologies Awarded EUR 1.3 Million Innovation Credit From Dutch Government
2. Occlutech Wins Dutch Appeal Court Ruling Against AGA Medical
3. Leading Dutch Cancer Center Commences Treatments Using New TrueBeam from Varian Medical Systems
4. Dutch Public-Private Partnership Invests 28 Million Euro on Research Into Personalized Medicine
5. Maxygen, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
6. Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer
7. Maxygen, Inc. Commences Dutch Auction Tender Offer to Repurchase 6,557,377 Shares of Common Stock
8. Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for Modified Dutch Auction Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note
9. Par Pharmaceutical Announces Modified Dutch Auction Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010
10. Agendias MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines
11. Dutch Top Institute Allocates 150 Million Euro to R&D Projects Targeting Early Diagnosis and Treatment of Disease
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Investors"), pursuant to which BioLight and the New Investors ... Ltd. subsidiary ("IOPtima") via a private placement. The financing ... its innovative IOPtimate™ system used in the treatment of ... pathway process for the IOPtimate™ system with the U.S. ...
(Date:11/25/2015)... -- --> --> ... das Patent über eine neue Hepatitis-B-Behandlung, welches sie gemeinsam ... Enyo Pharma vergeben haben. Im Rahmen ... von Edelris gemeinsam mit seinen Partnern Inserm und Poxel ... identifiziert, und es wurden neue Inhaltsstoffe entdeckt, die zu ...
(Date:11/24/2015)... SAN CARLOS, Calif. , Nov. 24, ... ), a leader in non-invasive genetic testing ... today announced that it will present at ... Conference in New York on Wednesday, December 2, 2015 at 1:00 p.m. ... discuss the Company,s financial results, business activities ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... , ... The McHenry County law firm of Botto Gilbert Lancaster, PC ... J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant David ... 130884WC. , According to court documents, Adcock testified that on May 10, 2010 he ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Beddit® has launched ... Classic sleep tracking systems. The new app features a more intuitive SleepScore™ that rates ... how well you slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes ...
(Date:11/25/2015)... D.C. (PRWEB) , ... November 25, 2015 , ... Today, ... fatalities on our nation’s roadways has dropped below 10,000 for the first time since ... 10,076 in 2013. , According to data released by the National Highway Traffic Safety ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract Development and ... of its current state of the art research, development and manufacturing facility outside ... its manufacturing capacity as well as to support its clients’ growing research and ...
(Date:11/25/2015)... ... 2015 , ... Since its launch in 2012, the Regenestem ... cell therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent ... (RTM). , Organizations are required to hold a registered trademark in order to ...
Breaking Medicine News(10 mins):